Regulation ChangeLiveProposed RegulationLive RegulationNews
FDA withdraws proposed rule on standardized asbestos testing methods for talc-containing cosmetic products (MoCRA Section 3505)
EU CLP (Regulation (EC) No 1272/2008) – Harmonised Classification & Labelling (CLH) for talcU.S. Food and Drug Administration (FDA)US
Announced
Nov 28, 2025
Description
FDA published a Federal Register notice withdrawing its proposed rule that would have established standardized testing methods for detecting and identifying asbestos in talc-containing cosmetic products (a MoCRA-related proposal). For compliance teams, this means the previously proposed federal framework for standardized talc/asbestos testing methods is not proceeding as proposed, and companies should monitor for a replacement proposed rule to satisfy MoCRA section 3505. The withdrawal affects regulatory planning for cosmetics quality/testing programs, supplier specifications, and method validation strategies tied to FDA-standardized methods.